Keystone Law

Corporate and Finance

Charles is a highly experienced corporate finance lawyer with extensive experience in advising biotech, medtech, tech and pharma clients on equity financings, IPOs, mergers, and other corporate transactions.

Charles has acted for a wide range of clients, including startups and university spinouts on seed financings, early-stage companies on Series A rounds, biotech companies on IPOs and secondary financings, venture capital funds investing in unlisted biotech companies, pharma companies taking strategic stakes in unlisted biotech companies, selling shareholders in biotech and medtech companies on private M&A transactions, and public company takeovers of biotech and medtech companies.

Charles regularly mentors companies participating in the Biotech Industry Association Pulse Programme and KQ Labs Accelerator Programme.